Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - TOTAL EQUITY
Total Equity VKTX - Viking Therapeutics, Inc.
348 M
LAST VALUE
31.37%
2 YEAR CAGR
3.19%
5 YEAR CAGR
106.24%
10 YEAR CAGR